These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16597666

  • 1. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
    Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
    [Abstract] [Full Text] [Related]

  • 2. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS.
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [Abstract] [Full Text] [Related]

  • 3. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
    Wu ZH, Lai RY, Yip YW, Chan WM, Lam DS, Lai TY.
    Retina; 2011 Jan; 31(7):1378-86. PubMed ID: 21836413
    [Abstract] [Full Text] [Related]

  • 4. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
    Chan WM, Lai TY, Lai RY, Liu DT, Lam DS.
    Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
    [Abstract] [Full Text] [Related]

  • 5. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK, Chang CK, Peng CH.
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [Abstract] [Full Text] [Related]

  • 6. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A, Kawamura A, Mori R, Fujita K, Yuzawa M.
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [Abstract] [Full Text] [Related]

  • 7. One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Fujita K, Imamura Y, Shinoda K, Matsumoto CS, Mizutani Y, Hashizume K, Mizota A, Yuzawa M.
    Ophthalmology; 2015 Mar; 122(3):555-61. PubMed ID: 25444637
    [Abstract] [Full Text] [Related]

  • 8. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V, Vysloužilová D, Uher M.
    Semin Ophthalmol; 2018 Mar; 33(5):690-699. PubMed ID: 29252091
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study.
    Gao T, Qu J, Xiao J, Hu J, Zhao M.
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1429-1439. PubMed ID: 29869216
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M.
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [Abstract] [Full Text] [Related]

  • 11. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
    Liu Y, Li L, Xu G, Wang W.
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
    [Abstract] [Full Text] [Related]

  • 12. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
    Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM, Aizman A.
    Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
    [Abstract] [Full Text] [Related]

  • 13. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
    Arif F, Pryds A, Larsen M.
    Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
    [Abstract] [Full Text] [Related]

  • 14. Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
    Fujita K, Yuzawa M, Mori R.
    Retina; 2011 Apr; 31(4):772-8. PubMed ID: 20890236
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F, Eandi CM, Ventre L, Rigault de la Longrais RC, Grignolo FM.
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
    Moon JW, Yu HG, Kim TW, Kim HC, Chung H.
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
    [Abstract] [Full Text] [Related]

  • 17. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.
    Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK.
    Br J Ophthalmol; 2003 Dec; 87(12):1453-8. PubMed ID: 14660450
    [Abstract] [Full Text] [Related]

  • 18. [Photodynamic therapy for chronic central serous chorioretinopathy and diffuse retinal epitheliopathy].
    Cornut PL, Quaranta-El Maftouhi M, Mauget-Faÿsse M.
    J Fr Ophtalmol; 2012 Feb; 35(2):82-7. PubMed ID: 21889817
    [Abstract] [Full Text] [Related]

  • 19. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB, Mohr JK, Ossewaarde-van Norel A, den Hollander AI, Keunen JE, Hoyng CB, Boon CJ.
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.
    Karakus SH, Basarir B, Pinarci EY, Kirandi EU, Demirok A.
    Eye (Lond); 2013 May; 27(5):612-20. PubMed ID: 23519277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.